Chemoinformaics analysis of gamma-guanidino-n-butyric acid
Molecular Weight | 759.812 | nRot | 13 |
Heavy Atom Molecular Weight | 702.356 | nRig | 23 |
Exact Molecular Weight | 759.397 | nRing | 4 |
Solubility: LogS | -0.654 | nHRing | 3 |
Solubility: LogP | -4.187 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 9 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 109 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 52 | No. of Aromatic Carbocycles | 0 |
nHetero | 24 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 57 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 28 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 9 | No. of Arom Atom | 0 |
No. of Oxygen atom | 15 | No. of Arom Bond | 0 |
nHA | 21 | APOL | 106.697 |
nHD | 16 | BPOL | 65.0468 |
QED | 0.115 |
Synth | 5.544 |
Natural Product Likeliness | 1.111 |
NR-PPAR-gamma | 0.005 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.914 |
HIA | 1 |
CACO-2 | -6.228 |
MDCK | 0.000423522 |
BBB | 0.447 |
PPB | 0.104408 |
VDSS | 0.123 |
FU | 0.850902 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.002 |
CYP2c19-inh | 0.017 |
CYP2c19-sub | 0.053 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.001 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.132 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.035 |
CL | 0.791 |
T12 | 0.891 |
hERG | 0.298 |
Ames | 0.098 |
ROA | 0.008 |
SkinSen | 0.777 |
Carcinogencity | 0.02 |
EI | 0.088 |
Respiratory | 0.175 |
NR-Aromatase | 0.009 |
Antiviral | Yes |
Prediction | 0.709321 |